What to Know About Two Recently Approved Drugs for Interstitial Lung Disease
YOUR LINK HERE:
http://youtube.com/watch?v=YxVzPY0wsts
Julie R. Gralow, MD, Director, Breast Medical Oncology, Seattle Cancer Care Alliance (SCCA), discusses the side effects associated with the administration of zoledronic acid (Zometa) in the adjuvant setting for postmenopausal patients with breast cancer. • For most information on breast cancer, visit http://www.onclive.com/specialty/brea...
#############################
